Abstract P5-11-08: Immunogenicity of eflapegrastim in a phase 2 open-label dose-ranging study of eflapegrastim in breast cancer patients receiving TC regimen
Vacirca, JL, Papai, Z, Agajanian, R, Horvath, Z, Makharadze, R, Ibrahim, E, Koli, P, Reddy, G, Tedesco, KL, McGregor, K, Schwartzberg, LS
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P5-11-09: Sustained efficacy of eflapegrastim in breast cancer patients in a phase 2, open-label, dose-ranging study
Vacirca, JL, Agajanian, R, Papai, Z, Horvath, Z, Makharadze, R, Ibrahim, EN, Choi, MR, Song, T, Tedesco, KL, McGregor, K, Schwartzberg, LS
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract OT3-02-13: Randomized phase 3 study of a novel, long-acting G-CSF (SPI-2012) versus pegfilgrastim in the management of chemotherapy-induced neutropenia in early-stage breast cancer patients receiving docetaxel and cyclophosphamide (TC) (ADVANCE study)
Schwartzberg, L, Vacirca, JL, Hager, SJ, Adoo, CS, Ibrahim, EN, Bhat, G, Choi, MR, Allen, LF, Tedesco, KL, Agajanian, R
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract P1-01-01: Circulating tumor cell number and CTC-endocrine therapy index predict clinical outcomes in ER positive metastatic breast cancer patients: Results of the COMETI Phase 2 trial
Paoletti, C, Regan, MM, Liu, MC, Marcom, PK, Hart, LL, Smith, JW, Tedesco, KL, Amir, E, Krop, IE, DeMichele, AM, Goodwin, PJ, Block, M, Aung, K, Cannell, EM, Darga, EP, Baratta, PJ, Brown, ME, McCormack, RT, Hayes, DF
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P1-10-05: Randomized phase 2, open-label, dose-ranging study of a novel, long-acting G-CSF (SPI-2012) or pegfilgrastim for the management of neutropenia in patients with breast cancer (BC) treated with (Neo) adjuvant chemotherapy with docetaxel + cyclophosphamide (TC)
Vacirca, JL, Chan, A, Mezei, K, Adoo, CS, Papai, Z, McGregor, K, Okera, M, Horvath, Z, Landherr, L, Hanslik, J, Hager, SJ, Ibrahim, EN, Ghazal, H, Rostom, M, Bhat, G, Choi, MR, Allen, LF, Tedesco, KL, Agajanian, R, Lang, I
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Docetaxel Combined With Trastuzumab Is an Active Regimen in HER-2 3+ Overexpressing and Fluorescent In Situ Hybridization–Positive Metastatic Breast Cancer: A Multi-Institutional Phase II Trial
TEDESCO, K. L, THOR, A. D, EDGERTON, S, SLEDGE, G. W, JOHNSON, D. H, SHYR, Y, BLUM, K. A, GOLDSTEIN, L. J, GRADISHAR, W. J, NICHOLSON, B. P, MERKEL, D. E, MURREY, D
Published in Journal of clinical oncology (15.03.2004)
Published in Journal of clinical oncology (15.03.2004)
Get full text
Journal Article
A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas
Tedesco, Karen L., Berlin, Jordan, Rothenberg, Mace, Choy, Hak, Wyman, Ken, Scott Pearson, Adrian, Daniel Beauchamp, Robert, Merchant, Nipun, Craig Lockhart, A., Shyr, Yu, Caillouette, Carol, Chakravarthy, Bapsi
Published in Radiotherapy and oncology (01.07.2005)
Published in Radiotherapy and oncology (01.07.2005)
Get full text
Journal Article
Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer
Tedesco, Karen L., Berlin, Jordan, Blanke, Charles D., Teng, Ming, Choy, Hak, Roberts, John, Beauchamp, R. Daniel, Leach, Steve, Wyman, Ken, Tarpley, John, Shyr, Yu, Caillouette, Carol, Chakravarthy, Bapsi
Published in International journal of radiation oncology, biology, physics (01.04.2005)
Published in International journal of radiation oncology, biology, physics (01.04.2005)
Get full text
Journal Article